S&P 500 Consumer Staples Sector SEC Filings — June 03, 2026

03-06-2026

PG&E's utility subsidiary, Pacific Gas and Electric Company, completed the sale of $2.2 billion aggregate principal amount of First Mortgage Bonds on June 3, 2026, comprising three tranches: $800 million of 5.050% bonds due 2031, $800 million of 5.600% bonds due 2036, and $600 million of 6.300% bonds due 2056. The issuance was executed under an underwriting agreement dated June 1, 2026, with BNP Paribas Securities Corp., Citigroup Global Markets Inc., MUFG Securities Americas Inc., and RBC Capital Markets LLC. This debt financing provides PG&E with long-term capital, but the relatively high coupon rates (5.050% to 6.300%) reflect elevated borrowing costs in the current interest rate environment.

• · The underwriting agreement was entered into on June 1, 2026, and the sale was completed on June 3, 2026.
• · The bonds are secured by first mortgage liens on the Utility's property.
• · The 2056 tranche carries the highest coupon at 6.300%, reflecting the longest maturity and potentially higher risk premium.
• · The issuance was conducted under a Thirty-Fourth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. as Trustee.

03-06-2026

Petco Health & Wellness (WOOF) reported Q1 2026 results with net sales of $1.50B (+0.2% YoY) and a return to positive comparable sales growth of 0.7%. Adjusted EBITDA improved to $97.3M (from $89.4M), and operating income surged 50.5% to $24.6M. However, the net loss widened to $15.1M (from $11.7M) and free cash flow remained negative at -$69.1M. The company reaffirmed its flat-to-1.5% FY 2026 net sales outlook and provided Q2 guidance with roughly 0.3% sales growth and Adjusted EBITDA of $110-112M.

• · Net loss per share (basic and diluted) was $(0.05) in Q1 2026 vs $(0.04) a year ago.
• · Gross profit margin improved 21 bps to 38.4% in Q1 2026.
• · Loss on extinguishment and modification of debt was $11.8M in Q1 2026 vs nil in Q1 2025.
• · Cash used in operating activities was $31.0M vs $15.5M in Q1 2025 (worsened).
• · Total debt decreased to $1.482B from $1.593B YoY.
• · The company received a partial IEEPA tariff refund in May 2026, but assumes no additional refunds for the remainder of the year.
• · Net store closures of 15-20 expected for full year 2026.
• · Full year 2026 Adjusted EBITDA guidance reaffirmed at $415M-$430M.

03-06-2026

Netskope reported strong Q1 FY2027 results with ARR up 29% YoY to $845M and revenue up 28% YoY to $201.6M, driven by AI security demand. However, GAAP loss from operations widened to $(108.7)M from $(45.4)M, and cash flow turned negative at $(53.9)M used in operations vs. $25.6M provided a year ago. CFO Drew Del Matto announced retirement, with a search for a successor underway.

• · GAAP gross margin improved to 74% from 69% YoY; Non-GAAP gross margin improved to 77% from 74%.
• · GAAP net loss per share improved to $(0.29) from $(0.76) YoY; Non-GAAP net loss per share improved to $(0.06) from $(0.28).
• · Cash and marketable securities stood at $1.1B.
• · Q2 FY2027 revenue guidance: $213M-$215M (25%-26% YoY growth).
• · Full year FY2027 revenue guidance: $879M-$883M (24%-25% YoY growth).
• · Full year FY2027 free cash flow margin guidance: 2% to 4%.
• · CFO Drew Del Matto to retire; will remain in role during successor search and transition to advisory role.
• · New product launches: AgentSkope (6 AI agents) and AI Command Center.
• · Partnerships: Deloitte for managed SASE, Anthropic for AI security, OpenAI for cyber program, Google Cloud for AI Guardrails.

03-06-2026

OPAL Fuels Inc. announced the commencement of construction on two renewable natural gas (RNG) facilities in Polk County, Georgia and Tallapoosa County, Alabama, which are 50/50 joint ventures with GFL Environmental. The facilities are expected to produce approximately 15 million gasoline gallon equivalents of RNG annually, enough to power about 800 Class 8 heavy-duty tractors per year, with the RNG to be distributed through OPAL's fueling station network.

• · The two RNG facilities are owned jointly on a 50/50 basis by GFL Environmental and OPAL Fuels Inc.
• · OPAL intends to distribute the RNG through its existing RNG/CNG fueling station network.
• · Construction commencement was announced on June 3, 2026.
• · The filing includes standard cautionary language regarding forward-looking statements.

03-06-2026

Smithfield Foods, Inc. held its 2026 Annual Meeting on June 2, 2026, where shareholders elected all three director nominees, ratified Ernst & Young LLP as the independent auditor for fiscal year ending January 3, 2027, and approved the non-binding advisory vote on named executive officer compensation for fiscal 2025. All proposals passed with strong shareholder support, though director Wan Long received the lowest 'For' votes at 93.5% of votes cast (excluding broker non-votes), while Raymond A. Starling received the highest at 98.5%.

• · Broker non-votes totaled 6,143,347 on director elections and the executive compensation proposal.
• · The ratification of Ernst & Young LLP received 379,298,050 'For' votes, 424,737 'Against', and 7,967 'Abstain'.
• · The advisory vote on executive compensation received 369,498,286 'For', 4,053,422 'Against', and 35,699 'Abstain'.
• · All three director nominees were elected to serve until the 2029 Annual Meeting.

03-06-2026

Wellgistics Health, Inc. (WGRX) filed Amendment No. 2 to its Current Report on Form 8-K on June 3, 2026, solely to replace and refile Exhibit 4.3 (Form of Placement Agent Warrant). No other disclosures from the original May 29, 2026 filing or Amendment No. 1 are modified, and no subsequent events are reflected.

• · This is an amendment to correct/refile only the Placement Agent Warrant exhibit (Exhibit 4.3) originally included in Amendment No. 1 filed on June 2, 2026.
• · The original Current Report was filed on May 29, 2026, with the earliest event reported on May 27, 2026.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.

03-06-2026

Helmerich & Payne, Inc. declared a quarterly cash dividend of $0.25 per share, payable on September 1, 2026, to stockholders of record as of August 18, 2026. The dividend was approved by the Board of Directors on June 3, 2026. No prior-period comparison or financial performance data is provided in this filing.

• · Dividend payable on September 1, 2026
• · Record date: August 18, 2026
• · Board meeting held on June 3, 2026

03-06-2026

Estée Lauder filed an 8-K/A on June 3, 2026, providing details on additional initiatives approved under its expanded Profit Recovery and Growth Plan (PRGP) restructuring program. Since April 29, 2026, the company approved $134 million in new charges (primarily employee severance and asset-related costs) for value chain optimization, enabling function re-invention, go-to-market model acceleration, and digital transformation. Cumulative charges approved through May 28, 2026 total $1,551 million, within the updated expected range of $1,500–$1,700 million, but the program's total expected cost has increased from the original $500–$700 million estimate.

• · The Restructuring Program is expected to be substantially completed by the end of fiscal 2027.
• · Cumulative employee-related costs approved through May 28, 2026 total $970 million, representing 85% of total restructuring charges.
• · Newly approved initiatives include reduction of point-of-sale demonstration roles as part of go-to-market model acceleration.
• · The company expects future cash expenditures to be funded from cash provided by operations.
• · The original restructuring program estimate of $500–$700 million has been revised upward three times, now at $1,500–$1,700 million.

03-06-2026

Farmer Mac's Board declared a quarterly dividend of $0.2769097 per share on its 6.875% Series I Preferred Stock, payable July 17, 2026 to holders of record as of July 1, 2026. This dividend covers the period from May 19, 2026 to July 17, 2026. Dividends for the common stock and five other preferred series (Series D–H) were previously declared on May 13, 2026, and this filing adds the Series I dividend declaration.

• · Record date for the Series I dividend is July 1, 2026; payment date is July 17, 2026.
• · Dividend period is from May 19, 2026 (not inclusive) to July 17, 2026 (inclusive).
• · No negative or flat metrics are included in this filing—it is a routine dividend declaration.

03-06-2026

Five Below, Inc. reported outstanding Q1 FY2026 results with net sales surging 32.5% YoY to $1.2856B and comparable sales increasing 22.7%, driven by broad-based growth across merchandising worlds and demographic segments. GAAP diluted EPS more than tripled to $2.21 from $0.75, while the company raised its full-year 2026 sales and EPS outlook. However, the company's outlook for Q2 implies a significant sequential deceleration in comparable sales growth to approximately 7-9% and a sharp drop in net income to $64M-$71M range, reflecting a cautious stance on potential tariff impacts and macroeconomic uncertainty.

• · Adjusted diluted EPS of $2.22 compared to $0.86 in prior year, a 158% increase.
• · Effective tax rate declined to 24.3% from 27.2%, providing a tailwind to net income.
• · Full year FY2026 net income outlook range: $480M to $502M (GAAP); adjusted $482M to $504M.
• · Full year FY2026 diluted EPS outlook: $8.62 to $9.02 (GAAP); adjusted $8.65 to $9.05.
• · The company ended Q1 with $638.9M cash and equivalents plus $474.4M in short-term investment securities, against zero drawn on its line of credit.
• · Inventories increased 15.8% YoY, while cash from operations nearly doubled to $227.2M.
• · Q2 FY2026 net income outlook implies a significant sequential decline from Q1's $123.1M to a range of $64M-$71M (GAAP).
• · Capital expenditures for full year FY2026 expected between $230M and $250M.

03-06-2026

Campbell Fund Trust filed an 8-K on June 3, 2026, reporting the unregistered sale of equity securities (Units of Beneficial Interest) effective May 31, 2026. The aggregate consideration was $6,986,653.81 in cash across three series, with Series A receiving $3,278,000.00, Series D $1,654,509.81, and Series W $2,054,144.00. The sales were conducted under Section 4(2) of the Securities Act and Regulation D, indicating a private placement to existing and/or new unitholders.

• · The securities were sold in reliance on the exemption from registration under Section 4(2) of the Securities Act and Regulation D, indicating a private placement.
• · The filing was made under Item 3.02 (Unregistered Sales of Equity Securities).
• · The report was signed by Thomas P. Lloyd, General Counsel of Campbell Fund Trust.

03-06-2026

Costco reported strong financial results for the 12 and 36 weeks ended May 10, 2026, with total revenue increasing 11.6% to $70.5 billion (12-week) and 9.7% to $207.4 billion (36-week) year-over-year. Net income grew 15.2% to $2.19 billion (12-week) and 13.5% to $6.23 billion (36-week), driven by higher net sales and membership fee growth. However, comprehensive income for the 12-week period fell 4.0% to $2.14 billion due to a $52 million foreign-currency translation loss, while operating cash flow increased 17.6% to $11.13 billion.

• · Diluted EPS for 12-week period rose to $4.93 from $4.28 YoY (up 15.2%)
• · Diluted EPS for 36-week period increased to $14.01 from $12.34 YoY (up 13.5%)
• · Operating income for 12-weeks: $2,815M vs $2,530M prior year (up 11.3%)
• · Operating income for 36-weeks: $7,884M vs $7,042M prior year (up 12.0%)
• · Interest income and other, net grew to $155M (12-week) from $85M prior year (+82.4%)
• · Interest expense decreased slightly from $35M to $32M (12-week)
• · Cash dividend declared for the quarter: $652M, up from $577M in prior-year period
• · Repurchases of common stock: $603M (36-week) vs $623M prior year
• · Capital expenditures (additions to PP&E) increased to $4,228M from $3,532M (19.7% increase)
• · Total assets grew to $86.4B from $77.1B (up 12.1% since August 31, 2025)

03-06-2026

FingerMotion, Inc. announced plans to expand into modular AI-focused edge computing facilities to support localized AI processing and inference workloads, building on its existing telecom and big data operations. The initiative targets the growing edge AI inference market with modular, micro-grid powered infrastructure for faster deployment and lower capital requirements than hyperscale data centers. However, the announcement is forward-looking with no specific financial commitments, timelines, or revenue projections disclosed.

• · The initiative is a strategic extension of FingerMotion's existing telecommunications and technology platform operations.
• · The company's approach focuses on edge-based AI inference infrastructure, not hyperscale cloud data center development.
• · Target sectors include manufacturing, logistics, smart city systems, healthcare, transportation, and industrial automation.
• · The modular design is intended to reduce deployment timelines compared to traditional large-scale data centers that can require multiple years to complete.
• · The company expects the initiative to create additional opportunities for recurring infrastructure-related revenue streams.

03-06-2026

Glaukos Corporation held its annual meeting on May 28, 2026, where stockholders voted on three proposals. All proposals passed, including the election of two Class II directors (Denice M. Torres and Aimee S. Weisner), a non-binding advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor for 2026. However, Denice M. Torres received a significant number of withheld votes (11,169,168), indicating notable shareholder dissent, while the compensation vote also had 4,272,830 against votes.

• · The annual meeting was held on May 28, 2026, and the proxy statement was filed on April 16, 2026.
• · Proposal 3 (ratification of auditor) had no broker non-votes, indicating all shares voted.
• · Denice M. Torres received 40,843,317 votes for and 11,169,168 withheld, representing about 21.5% withheld votes.
• · Aimee S. Weisner received 49,397,952 votes for and 2,614,533 withheld, with a much lower dissent rate.
• · The advisory vote on executive compensation had 4,272,830 against votes (about 8.2% of votes cast), indicating some shareholder concerns.

03-06-2026

Katapult Holdings, Inc. entered into a Third Amendment and Limited Waiver to its Amended and Restated Loan and Security Agreement on June 2, 2026. The amendment removes the Minimum Trailing Net Three-Month Originations covenant and reduces the advance rate under the loan. The filing notes a series of prior waivers and amendments throughout 2025 and 2026, indicating ongoing covenant compliance challenges.

• · The amendment follows at least eleven prior limited waivers and two prior amendments executed between September 2025 and May 2026.
• · The Third Amendment removes the Minimum Trailing Net Three-Month Originations financial covenant.
• · The Third Amendment reduces the advance rate under the Loan Agreement.
• · The Loan Agreement was originally dated June 12, 2025.

03-06-2026

Celularity Inc. appointed Rick Gonzalez as Chief Commercial Officer, effective May 29, 2026, to oversee global commercial strategy for cenplacel-L and Lifebank. While the company noted early commercial traction and Lifebank sales in 2025, no specific revenue figures or growth rates were disclosed, and the filing highlights ongoing risks typical of a pre-revenue stage biotechnology company.

• · Rick Gonzalez previously served as Chief Commercial Officer of Alume Biosciences, President/CEO/Director of Navidea Biopharmaceuticals, and SVP Global Operations at Spectrum Pharmaceuticals.
• · At Navidea, Mr. Gonzalez drove 2.5x year-over-year revenue growth.
• · At Spectrum Pharmaceuticals, he helped scale global revenue from $7.7M to approximately $300M.
• · No specific financial figures for Celularity's current revenue or Lifebank sales were provided in the filing.
• · The filing contains standard cautionary language regarding forward-looking statements and risks.

03-06-2026

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) announced the pricing of a best-efforts offering of 1,449,300 common shares at $3.25 per share, with expected gross proceeds of approximately $4.7 million. The offering, placed by ThinkEquity and expected to close June 2, 2026, will be used for working capital, general corporate purposes, and advancing business objectives. The company is a clinical-stage biotechnology company developing novel immunotherapies for cancer. The filing is positive in that it provides additional capital, but the offering dilutes existing shareholders by approximately 1.45 million shares at a price that may reflect current market conditions.

• · Offering priced at $3.25 per share, a best-efforts offering of 1,449,300 common shares.
• · Total gross proceeds expected to be approximately $4.7 million.
• · The offering is being conducted under an effective shelf registration statement (Form S-3) filed with the SEC on January 22, 2024.
• · The company is relying on TSX exemption for interlisted issuers on Nasdaq.
• · ThinkEquity is acting as sole placement agent.
• · Expected closing date: June 2, 2026.

03-06-2026

Worthington Steel, Inc. (NYSE: WS) completed its voluntary public takeover of Kloeckner & Co SE, acquiring approximately 62% of outstanding shares, and announced a Delisting Tender Offer for remaining shares at EUR 11.00 cash per share. The combined entity expects increased scale, operational efficiencies, and broader geographic presence, but remaining shareholders face significantly reduced liquidity. Kloeckner reported sales of €6.4 billion in fiscal 2025, and both companies each employ roughly 6,000 people.

• · Worthington Steel currently holds approximately 62% of Kloeckner’s outstanding shares following the Takeover Offer.
• · The Delisting Offer will be at EUR 11.00 cash per Kloeckner share (ISIN DE000KC01000).
• · Kloeckner had sales of approximately €6.4 billion in fiscal year 2025.
• · Worthington Steel operates 37 facilities across seven states and 10 countries, with about 6,000 employees.
• · Kloeckner has about 110 warehouse/processing locations, primarily in North America and DACH region, serving more than 60,000 customers and employing more than 6,000 people.
• · After delisting, Kloeckner shares will no longer trade on a regulated market in Germany, leading to reduced liquidity and limited price discovery.
• · The Delisting Offer is not subject to closing conditions or minimum acceptance threshold.
• · BaFin will review the Delisting Offer Document before publication.

03-06-2026

Ferrellgas Partners, L.P. filed an 8-K on June 3, 2026, announcing a teleconference and webcast on June 5, 2026, to discuss its results of operations for the third fiscal quarter ended April 30, 2026. The webcast will begin at 9:00 a.m. Central Time, and questions may be submitted via email. No financial results or period-over-period comparisons are provided in this filing.

• · The teleconference will be held on Friday, June 5, 2026.
• · The webcast link is https://edge.media-server.com/mmc/p/nrae97ca.
• · Questions may be submitted via InvestorRelations@ferrellgas.com.
• · The filing is a Regulation FD Disclosure (Item 7.01).

03-06-2026

Coca-Cola Europacific Partners plc (CCEP) disclosed the grant of Performance Share Units (PSUs) to two PDMRs: CEO Damian Gammell (109,856 PSUs) and CCO Stephen Lusk (1,568 PSUs) under the company's Long-Term Incentive Plan. The awards have a zero exercise price and will vest on March 26, 2029, subject to continued service and performance conditions. No financial results or period-over-period comparisons are included in this filing.

• · The PSUs have a grant price of USD $0 per share.
• · The transaction date is June 3, 2026.
• · The PSUs vest on March 26, 2029.
• · The transactions took place outside of a trading venue.

03-06-2026

KKR Enhanced US Direct Lending Fund-L Inc. declared a dividend of $9.96 per share on its common shares, payable on or about June 30, 2026 to shareholders of record as of May 29, 2026. The filing is an 8-K under Item 8.01 (Other Events) and does not include any financial results or period-over-period comparisons.

• · Dividend record date is May 29, 2026 (close of business).
• · Dividend payment date is on or about June 30, 2026.
• · The company is an emerging growth company as defined under SEC rules.

03-06-2026

DBK Financial Counsel, LLC filed its Form 13F-HR for the quarter ended March 31, 2026, reporting a total of 59 positions with aggregate market value of approximately $132,074,219. The filing shows a diversified portfolio weighted heavily toward ETFs, with top holdings including SPDR Series Trust (State Street SPDR, $17.1M), Vanguard Tax-Managed FTSE Dev Mkt ETF ($8.1M), and SPDR S&P 500 ETF ($7.7M). The filing does not include a prior-period comparison, so trends and period-over-period changes cannot be assessed.

• · All 59 positions are held with sole voting and dispositive power; no shared or no-ownership interests are reported.
• · ETF holdings dominate the portfolio, with significant allocations to Dimensional and American Century funds across US, international, and real estate sectors.
• · Individual stocks held include Apple ($1.6M), NVIDIA ($2.3M), Amazon ($0.5M), Alphabet Class A ($0.3M) and Class C ($0.9M), Microsoft ($0.7M), and Cisco ($0.2M).
• · Gold exposure is included via iShares Gold Trust ($0.4M) and SPDR Gold Trust ($1.2M).
• · The filing date is June 3, 2026, within the 45-day deadline for the quarter ended March 31, 2026.

03-06-2026

Stillwater Private Wealth, LLC filed its quarterly 13F-HR for the period ending March 31, 2026, reporting a total of 78 equity holdings with an aggregate market value of approximately $118,176,000. The portfolio is heavily weighted toward ETFs, with the largest positions in Schwab U.S. Broad Market ETF ($7.7M), Alpha Architect 1-3 Month Box ETF ($14.2M), and Schwab U.S. Large-Cap ETF ($6.0M). The filing reflects a diversified, multi-asset strategy with significant exposure to U.S. equities, fixed income, commodities, and inflation-protected securities.

• · The largest single holding is Alpha Architect 1-3 Month Box ETF with a market value of $14,162,000 (121,786 shares), representing a cash-equivalent position.
• · The second-largest holding is Schwab U.S. Broad Market ETF valued at $7,729,000 (307,962 shares).
• · The portfolio includes a notable gold ETF position: abrdn Physical Gold Shares ETF valued at $6,324,000 (141,751 shares).
• · Fixed income exposure is significant, with positions in Schwab Intermediate-Term US Treasury ETF ($2,027,000), iShares TIPS Bond ETF ($3,374,000), and iShares 0-5 Year TIPS Bond ETF ($2,810,000).
• · Commodity exposure includes iPath Bloomberg Commodity Index Total Return ETN ($1,135,000) and Harbor Commodity All-Weather Strategy ETF ($676,000).
• · The portfolio holds a single cryptocurrency-related equity: HIVE Digital Technologies Ltd (20,000 shares, $38,000).
• · No period-over-period comparisons are available as this is a single filing without prior quarter data.

03-06-2026

FS KKR Capital Corp. (FSK) entered into a Ninth Amendment to its Loan and Servicing Agreement for its wholly owned subsidiary CCT Tokyo Funding LLC, extending the maturity date from June 2, 2026, to September 30, 2026. The amendment involves Sumitomo Mitsui Banking Corporation as administrative agent and lender. While the extension provides near-term liquidity relief, the short duration (less than 4 months) suggests ongoing refinancing needs.

• · The original Loan and Servicing Agreement was dated December 2, 2015.
• · The Ninth Amendment was entered into on June 1, 2026, and filed on June 3, 2026.
• · The extension is from June 2, 2026, to September 30, 2026, a period of approximately 120 days.
• · No financial terms or amounts were disclosed in the filing.

03-06-2026

Reliance Global Group, Inc. (RELIW) received a Nasdaq notice on June 2, 2026, confirming that its common stock closing bid price had been at or above $1.00 per share for 10 consecutive business days (May 18–June 1, 2026), thereby regaining compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). The company had previously been notified of non-compliance on December 12, 2025, when its stock traded below $1.00 for 30 consecutive business days. The matter is now closed, and the company issued a press release on June 3, 2026, announcing the compliance resolution.

• · The company's common stock trades under the symbol EZRA on the Nasdaq Capital Market.
• · The par value of the common stock is $0.086 per share.
• · The compliance notice was based on the closing bid price over the 10 consecutive business days from May 18, 2026 through June 1, 2026.
• · The initial non-compliance notice was received on December 12, 2025.

03-06-2026

Newcleo Ltd., a Franco-Italian SMR start-up, announced its intention to go public via a merger with SPAC NewHold Investment Corp III, which holds $209 million in cash, with an additional $220 million raised from private investors, targeting a valuation of €2.4 billion. The company has secured nearly €1 billion since its creation and is pursuing U.S. government support, including access to surplus plutonium for MOX fuel. However, doubts persist about its business model, and it may not be selected for Phase 2 of France's France 2030 program, while it still needs to secure a plutonium supply agreement with Orano for its French projects.

• · Newcleo is considering building at least one SMR at the Savannah River site in South Carolina and has begun preliminary procedures with the U.S. Nuclear Regulatory Commission.
• · The public debate for French projects (Chinon demonstrator and Nogent MOX plant) runs from April 2 to July 30, 2026.
• · Newcleo has not yet reached an agreement with Orano for plutonium supply in France.
• · The company is in contact with data center operators and other industrial companies interested in its SMRs.
• · France has historically favored sodium-cooled reactor technology (Phénix, Superphénix, Astrid), while Newcleo's lead-cooled technology is less mature.

03-06-2026

KKR FS Income Trust entered into a Third Amendment to its Senior Secured Revolving Credit Agreement, dated May 28, 2026, which increases aggregate commitments and adds new lenders. The amendment reaffirms existing liens and guarantees, and the borrower represents that no default or event of default is continuing. No specific financial figures or performance metrics are disclosed in this filing.

• · The amendment was dated May 28, 2026 and filed on June 3, 2026.
• · New lenders joined the credit facility, increasing aggregate commitments.
• · The borrower reaffirmed that no default or event of default is continuing.
• · Existing liens and guarantees under the Guarantee and Security Agreement remain in full force and effect.
• · The amendment includes a waiver of jury trial provision.

03-06-2026

Benchmark 2026-V22 Mortgage Trust filed an 8-K on June 3, 2026, disclosing that the servicing and administration of the Del Rey Campus Whole Loan are being transferred from the Benchmark 2026-V21 PSA to the WFCM 2026-5C9 PSA, effective upon issuance of the WFCM 2026-5C9 Certificates. The filing details the fee structures for the outside special servicer under the new agreement, including special servicing, workout, and liquidation fees, as well as property inspection requirements. No financial performance data or period-over-period comparisons are provided in this filing.

• · The Del Rey Campus Whole Loan was originally required to be serviced under the Benchmark 2026-V21 PSA, filed as Exhibit 4.5 to the Form 8-K on May 12, 2026.
• · The Servicing Shift Lead Note was contributed to the WFCM 2026-5C9 Securitization on May 28, 2026.
• · The WFCM 2026-5C9 PSA is dated as of May 1, 2026.
• · Property inspection requirements commence in 2027, with a deadline of December 31, 2028.
• · The filing includes Exhibit 4.1, the WFCM 2026-5C9 PSA.

03-06-2026

On May 28, 2026, Healthy Choice Wellness Corp. entered into an Exchange Agreement with certain holders of its indebtedness to exchange $1,431,000 of principal for 5,315,450 shares of Class A common stock at $0.27 per share. Following the exchange, approximately $2,100,000 remains unpaid under the Credit Agreement. The transaction reduces debt but significantly dilutes existing shareholders.

• · The Notes were originally issued under a Loan and Security Agreement dated July 18, 2024.
• · Holders are subject to a 9.9% beneficial ownership limitation on conversion.
• · The exchange was executed on May 28, 2026, and reported on June 3, 2026.
• · The company is an emerging growth company and has not elected to use the extended transition period for new accounting standards.